跳至主要内容
临床试验/ACTRN12605000665639
ACTRN12605000665639已完成不适用

A multi-centre, randomised, controlled trial of bronchoalveolar lavage (BAL) directed therapy to improve clinical outcomes in young children with cystic fibrosis.

HMRC0 个研究点目标入组 165 人开始时间: 2005年10月19日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
165

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
Years 至 6 Months(—)
性别
All

入选标准

  • All infants diagnosed with cystic fibrosis through the neonatal screening program in Queensland, New South Wales, South Australia, Victoria, Auckland and North Auckland Infants diagnosed with meconium ileus may be enrolled when diagnosis of cystic fibrosis is confirmed. A diagnosis of cystic fibrosis must be confirmed with a positive sweat chloride (Gibson Cooke with a chloride > 60mmol/l).Informed consent from parents or guardians.

排除标准

  • Informed consent cannot be obtained. Infant is severely ill at the time of diagnosis and requires ventilatory support. Family are planning to move overseas in the next few years.

研究者

发起方
HMRC

相似试验